Sunitinib versus Interferon Alfa in Metastatic Renal-Cell Carcinoma von Motzer, Robert J, Hutson, Thomas E, Tomczak, Piotr, Michaelson, M. Dror, Bukowski, Ronald M, Rixe, Olivier, Oudard, Stéphane, Negrier, Sylvie, Szczylik, Cezary, Kim, Sindy T, Chen, Isan, Bycott, Paul W, Baum, Charles M, Figlin, Robert A

Volltext

Inhibition of hypoxia-inducible factor-2α in renal cell carcinoma with belzutifan: a phase 1 trial and biomarker analysis von Choueiri, Toni K., Bauer, Todd M., Papadopoulos, Kyriakos P., Plimack, Elizabeth R., Merchan, Jaime R., McDermott, David F., Michaelson, M. Dror, Appleman, Leonard J., Thamake, Sanjay, Perini, Rodolfo F., Zojwalla, Naseem J., Jonasch, Eric

Volltext

Cabozantinib versus sunitinib as initial therapy for metastatic renal cell carcinoma of intermediate or poor risk (Alliance A031203 CABOSUN randomised trial): Progression-free surv... von Choueiri, Toni K., Hessel, Colin, Halabi, Susan, Sanford, Ben, Michaelson, M. Dror, Hahn, Olwen, Walsh, Meghara, Olencki, Thomas, Picus, Joel, Small, Eric J., Dakhil, Shaker, Feldman, Darren R., Mangeshkar, Milan, Scheffold, Christian, George, Daniel, Morris, Michael J.

Volltext

Belzutifan plus cabozantinib for patients with advanced clear cell renal cell carcinoma previously treated with immunotherapy: an open-label, single-arm, phase 2 study von Choueiri, Toni K, McDermott, David F, Merchan, Jaime, Bauer, Todd M, Figlin, Robert, Heath, Elisabeth I, Michaelson, M Dror, Arrowsmith, Edward, D'Souza, Anishka, Zhao, Song, Roy, Ananya, Perini, Rodolfo, Vickery, Donna, Tykodi, Scott S

Volltext

Detection of renal cell carcinoma using plasma and urine cell-free DNA methylomes von Nuzzo, Pier Vitale, Berchuck, Jacob E., Korthauer, Keegan, Spisak, Sandor, Nassar, Amin H., Abou Alaiwi, Sarah, Chakravarthy, Ankur, Shen, Shu Yi, Bakouny, Ziad, Boccardo, Francesco, Steinharter, John, Bouchard, Gabrielle, Curran, Catherine R., Pan, Wenting, Baca, Sylvan C., Seo, Ji-Heui, Lee, Gwo-Shu Mary, Michaelson, M. Dror, Chang, Steven L., Waikar, Sushrut S., Sonpavde, Guru, Irizarry, Rafael A., Pomerantz, Mark, De Carvalho, Daniel D., Choueiri, Toni K., Freedman, Matthew L.

Volltext

Radical cystectomy versus trimodality therapy for muscle-invasive bladder cancer: a multi-institutional propensity score matched and weighted analysis von Zlotta, Alexandre R, Ballas, Leslie K, Niemierko, Andrzej, Lajkosz, Katherine, Kuk, Cynthia, Miranda, Gus, Drumm, Michael, Mari, Andrea, Thio, Ethan, Fleshner, Neil E, Kulkarni, Girish S, Jewett, Michael A S, Bristow, Robert G, Catton, Charles, Berlin, Alejandro, Sridhar, Srikala S, Schuckman, Anne, Feldman, Adam S, Wszolek, Matthew, Dahl, Douglas M, Lee, Richard J, Saylor, Philip J, Michaelson, M Dror, Miyamoto, David T, Zietman, Anthony, Shipley, William, Chung, Peter, Daneshmand, Siamak, Efstathiou, Jason A

Volltext

Treatment sequences for advanced renal cell carcinoma: A health economic assessment von Deniz, Baris, Ambavane, Apoorva, Yang, Shuo, Altincatal, Arman, Doan, Justin, Rao, Sumati, Michaelson, M Dror

Volltext

Lenvatinib, everolimus, and the combination in patients with metastatic renal cell carcinoma: a randomised, phase 2, open-label, multicentre trial von Motzer, Robert J, Dr, Hutson, Thomas E, DO, Glen, Hilary, MD, Michaelson, M Dror, MD, Molina, Ana, MD, Eisen, Timothy, Prof, Jassem, Jacek, Prof, Zolnierek, Jakub, MD, Maroto, Jose Pablo, MD, Mellado, Begoña, MD, Melichar, Bohuslav, Prof, Tomasek, Jiri, MD, Kremer, Alton, MD, Kim, Han-Joo, PhD, Wood, Karen, PhD, Dutcus, Corina, MD, Larkin, James, FRCP

Volltext

Randomized, Placebo-Controlled, Phase III Trial of Sunitinib Plus Prednisone Versus Prednisone Alone in Progressive, Metastatic, Castration-Resistant Prostate Cancer von DROR MICHAELSON, M, OUDARD, Stephane, LAESTADIUS, Fredrik, ULLEN, Anders, BAHL, Amit, CASTELLANO, Daniel, GSCHWEND, Juergen, MAURINA, Tristan, CHOW MANEVAL, Edna, WANG, Shaw-Ling, LECHUGA, Maria Jose, PAOLINI, Jolanda, OU, Yen-Chuan, ISAN CHEN, SENGELØV, Lisa, SAAD, Fred, HOUEDE, Nadine, OSTLER, Peter, STENZL, Arnulf, DAUGAARD, Gedske, JONES, Robert

Volltext

Axitinib versus sorafenib as second-line treatment for advanced renal cell carcinoma: overall survival analysis and updated results from a randomised phase 3 trial von Motzer, Robert J, Dr, Escudier, Bernard, MD, Tomczak, Piotr, MD, Hutson, Thomas E, DO, Michaelson, M Dror, MD, Negrier, Sylvie, Prof, Oudard, Stephane, Prof, Gore, Martin E, Prof, Tarazi, Jamal, MD, Hariharan, Subramanian, MD, Chen, Connie, PharmD, Rosbrook, Brad, MS, Kim, Sinil, MD, Rini, Brian I, MD

Volltext

Antitumor Activity and Biomarker Analysis of Sunitinib in Patients With Bevacizumab-Refractory Metastatic Renal Cell Carcinoma von RINI, Brian I, DROR MICHAELSON, M, KIM, Sindy T, CHEN, Isan, GEORGE, Daniel J, ROSENBERG, Jonathan E, BUKOWSKI, Ronald M, SOSMAN, Jeffrey A, STADLER, Walter M, HUTSON, Thomas E, MARGOLIN, Kim, HARMON, Charles S, DEPRIMO, Samuel E

Volltext

Comparative effectiveness of axitinib versus sorafenib in advanced renal cell carcinoma (AXIS): a randomised phase 3 trial von Rini, Brian I, Dr, Escudier, Bernard, MD, Tomczak, Piotr, MD, Kaprin, Andrey, Prof, Szczylik, Cezary, MD, Hutson, Thomas E, DO, Michaelson, M Dror, MD, Gorbunova, Vera A, Prof, Gore, Martin E, Prof, Rusakov, Igor G, Prof, Negrier, Sylvie, Prof, Ou, Yen-Chuan, Prof, Castellano, Daniel, MD, Lim, Ho Yeong, Prof, Uemura, Hirotsugu, Prof, Tarazi, Jamal, MD, Cella, David, PhD, Chen, Connie, PharmD, Rosbrook, Brad, MS, Kim, Sinil, MD, Motzer, Robert J, MD

Volltext

Phase I LITESPARK-001 study of belzutifan for advanced solid tumors: Extended 41-month follow-up in the clear cell renal cell carcinoma cohort von Jonasch, Eric, Bauer, Todd M, Papadopoulos, Kyriakos P, Plimack, Elizabeth R, Merchan, Jaime R, McDermott, David F, Dror Michaelson, M, Appleman, Leonard J, Roy, Ananya, Perini, Rodolfo F, Liu, Yanfang, Choueiri, Toni K

Volltext

Randomized Controlled Trial of Annual Zoledronic Acid to Prevent Gonadotropin-Releasing Hormone Agonist–Induced Bone Loss in Men With Prostate Cancer von DROR MICHAELSON, M, KAUFMAN, Donald S, LEE, Hang, MCGOVERN, Francis J, KANTOFF, Philip W, FALLON, Mary Anne, FINKELSTEIN, Joel S, SMITH, Matthew R

Volltext

Overall Survival and Updated Results for Sunitinib Compared With Interferon Alfa in Patients With Metastatic Renal Cell Carcinoma von MOTZER, Robert J, HUTSON, Thomas E, GARCIA-DEL-MURO, Xavier, SOSMAN, Jeffrey A, SOLSKA, Ewa, WILDING, George, THOMPSON, John A, KIM, Sindy T, CHEN, Isan, XIN HUANG, FIGLIN, Robert A, TOMCZAK, Piotr, MICHAELSON, M. Dror, BUKOWSKI, Ronald M, OUDARD, Stéphane, NEGRIER, Sylvie, SZCZYLIK, Cezary, PILI, Roberto, BJARNASON, Georg A

Volltext

Phase II study of sunitinib in men with advanced prostate cancer von Dror Michaelson, M., Regan, M.M., Oh, W.K., Kaufman, D.S., Olivier, K., Michaelson, S.Z., Spicer, B., Gurski, C., Kantoff, P.W., Smith, M.R.

Volltext

Multidisciplinary Care and Pursuit of Active Surveillance in Low-Risk Prostate Cancer von AIZER, Ayal A, PALY, Jonathan J, OLUMI, Aria F, DROR MICHAELSON, M, D'AMICO, Anthony V, EFSTATHIOU, Jason A, ZIETMAN, Anthony L, NGUYEN, Paul L, BEARD, Clair J, RAO, Sandhya K, KAPLAN, Irving D, NIEMIERKO, Andrzej, HIRSCH, Michelle S, WU, Chin-Lee

Volltext

Sunitinib-associated hypertension and neutropenia as efficacy biomarkers in metastatic renal cell carcinoma patients von Donskov, Frede, Michaelson, M Dror, Puzanov, Igor, Davis, Mellar P, Bjarnason, Georg A, Motzer, Robert J, Goldstein, David, Lin, Xun, Cohen, Darrel P, Wiltshire, Robin, Rini, Brian I

Volltext

A Dose-Ranging Study of Cabozantinib in Men with Castration-Resistant Prostate Cancer and Bone Metastases von LEE, Richard J, SAYLOR, Philip J, GOLDIN, Jonathan G, SMITH, Matthew R, DROR MICHAELSON, M, ROTHENBERG, S. Michael, SMAS, Malgorzata E, MIYAMOTO, David T, GURSKI, Carol A, WANLING XIE, MAHESWARAN, Shyamala, HABER, Daniel A

Volltext

The radiopharmaceutical radium-223 has immunomodulatory effects in patients and facilitates anti-programmed death receptor-1 therapy in murine models of bone metastatic prostate ca... von Saylor, Philip J., Kozin, Sergey V., Matsui, Aya, Goldberg, Saveli I., Aoki, Shuichi, Shigeta, Kohei, Mamessier, Emilie, Smith, Matthew R., Michaelson, M. Dror, Lee, Richard J., Duda, Dan G.

Volltext